# Creatine as a Treatment Option for Depression in Methamphetamine Using Females

> **NCT01514630** · PHASE4 · COMPLETED · sponsor: **Perry Renshaw** · enrollment: 14 (actual)

## Conditions studied

- Depression
- Substance Abuse
- Substance Use
- Neuroimaging
- Dual Diagnosis

## Interventions

- **DRUG:** Creatine monohydrate

## Key facts

- **NCT ID:** NCT01514630
- **Lead sponsor:** Perry Renshaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01514630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01514630, "Creatine as a Treatment Option for Depression in Methamphetamine Using Females". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01514630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*